Top Sell
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.85 | €5.51 | 551.074% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.58 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.95 | €8.82 | 832.512% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 0 | 0 | €39.00 | €56.72 | 45.440% |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | €1.46 | €18.37 | 1157.945% |
| Immuron | 0 | 1 | 0 | 0 | €1.81 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.23 | - | - |
| Medigene AG | 1 | 2 | 0 | 0 | €1.19 | €1.00 | -15.612% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €11.00 | €22.00 | 100.000% |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.42 | €3.63 | 770.103% |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €1.09 | €2.00 | 83.570% |
| Acadia Pharmaceuticals | 28 | 1 | 0 | 0 | €15.00 | €31.78 | 111.894% |
| Bristol-Myers Squibb | 12 | 3 | 0 | 0 | €39.30 | €70.25 | 78.782% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €35.20 | €50.00 | 42.045% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 43.177% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.20 | €50.00 | 4070.142% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.78 | - | - |
| Moleculin Biotech Inc | 3 | 24 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| CEL-SCI Corp. | 0 | 4 | 0 | 0 | €1.20 | - | - |
| Agenus Inc. | 3 | 2 | 0 | 0 | €0.41 | €36.85 | 8804.785% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.48 | - | - |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.20 | €7.00 | 12.903% |
| Evoke Pharma Inc. | 0 | 23 | 0 | 0 | €0.43 | - | - |